Those numbers sound bigger than they are: even after the increase, only about 7 in 1,000 GLP-1 patients per year ended up with a hair loss diagnosis, versus roughly 4 to 5 in 1,000 on the other drugs
Ultimately, whether Mounjaro is the best choice for you should involve discussions with your healthcare provider , who can help weigh the benefits and risks specific to your health condition and lifestyle
The latest updates in clinical research, including the TRIUMPH-1 trial, are gathering more data on how different dosage levels impact weight loss and other health outcomes in both overweight and obese individuals
The individual properties of the various GLP-1 receptor agonists might enable incretin-based treatment of type 2 diabetes mellitus to be tailored to the needs of each patient
Patients typically start at injecting 1ml IM or SQ one to two times per week, and can titrate up or down by 0.5ml per dose depending on effectiveness and side effects
Our solutions are designed for reproducibility and mechanistic clarity, helping researchers explore complex pathways such as glucagon-mediated energy regulation with confidence